Coya Therapeutics develops biologic treatments that aim to restore regulatory T cell function for patients with serious diseases. It last closed at $3.02 on Nov 17, up 0.67% on the day. The average 12-month price target from 2 analysts is $14.00 (+363.6% from the last close), with a high of $16.00 and a low of $12.00.
Only 2 firms rated COYA in the past 90 days, not enough for a consensus
Average 12-month target
$14.00
▲ 363.6% upside
Based on 2 analysts who set a price target on COYA in the past 90 days. The average target is $14.00, with a high of $16.00 and a low of $12.00, compared with the last close of $3.02.
Low $12.00Avg $14.00High $16.00
Blue marker: last close $3.02
Highest target$16.00
Average target$14.00
Lowest target$12.00
Latest rating changes
BTIGReiterated
Sep 15Buy$16
Roth CapitalReiterated
Aug 24Buy$12
Chardan CapitalMaintained
Aug 12Buy$14
Roth CapitalInitiated
Jun 5Buy$12
Date
Firm
Action
Rating
Price target
Sep 15
BTIG
Reiterated
Buy
$16
Aug 24
Roth Capital
Reiterated
Buy
$12
Aug 12
Chardan Capital
Maintained
Buy
$14
Jun 5
Roth Capital
Initiated
Buy
$12
Loading…
Technical Analysis
COYA · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold
The stock is 15% below its 20 day and 40% below its 50 day average. It is 51% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 33), near oversold. The nearest support is the Pivot at $3.00, and the nearest resistance the Pivot R1 at $3.08.
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityHigh, 9.9%/day
Key levels
$6.6252 week high+119.2%
$4.55200 day average+50.7%
$4.51100 day average+49.3%
$4.2350 day average+40.1%
$3.4720 day average+14.9%
$3.47Swing high (Nov 10)+14.9%
$3.08Pivot R1+2.0%
$3.02Last close
$3.00Pivot−0.7%
$2.95Pivot S1−2.3%
$2.7252 week low−9.9%
$2.72Swing low (Nov 5)−9.9%
Indicators
RSI (14)
33.05
Weak, oversold below 30
Neutral
MACD
-0.36
Below its signal line
Bearish
Stochastic
21.7
Middle of its range
Neutral
ADX (14)
28.4
Trending down
Williams %R
-79.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
-76.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−4.4%
Change over 10 sessions
Bearish
ATR (14)
$0.30
Typical daily range, 9.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 20.6%/day
Key levels
$6.6252 week high+119.2%
$4.55200 day average+50.7%
$4.51100 day average+49.3%
$4.2350 day average+40.1%
$3.4720 day average+14.9%
$3.47Swing high (Nov 10)+14.9%
$3.08Pivot R1+2.0%
$3.02Last close
$3.00Pivot−0.7%
$2.95Pivot S1−2.3%
$2.7252 week low−9.9%
$2.72Swing low (Nov 5)−9.9%
Indicators
RSI (14)
34.11
Weak, oversold below 30
Neutral
MACD
-0.41
Below its signal line
Bearish
Stochastic
12.4
Near the bottom of its range
Oversold
ADX (14)
19.4
No clear trend
Williams %R
-88.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-183.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−31.1%
Change over 10 sessions
Bearish
ATR (14)
$0.62
Typical daily range, 20.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for COYA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how COYA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow COYA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How COYA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2022.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether COYA is in one of them and how their past COYA trades turned out.
Coya Therapeutics is a biotechnology company based in Houston, Texas. It is developing treatments that aim to restore the function of regulatory T cells, immune cells that help keep inflammation in check. Its lead candidate, COYA 302, is in clinical testing for amyotrophic lateral sclerosis and is also planned for frontotemporal dementia. The company's therapies are intended for patients with neurodegenerative, autoimmune and metabolic diseases.